To prospectively investigate the impact of total and central obesity on vascular mortality in patients undergoing coronary angiography. DESIGN: Prospective cohort study; mean follow-up 2.2 y. SUBJECTS: Men (n ¼ 513) and women (n ¼ 243) undergoing coronary angiography for the evaluation of coronary artery disease. MEASUREMENTS: Body mass index (BMI) was used as a measure of total obesity; waist-to-hip ratio (WHR) and waist circumference (WCf) as measures of central obesity. The primary study end point was vascular mortality; secondary study end points were total mortality, major coronary events, and cumulative vascular events. RESULTS: For both genders, BMI, WHR, and WCf correlated significantly with fasting plasma glucose, with HOMA insulin resistance, with triglycerides, and inversely with HDL cholesterol (Po0.001 for all correlations). In Cox regression analysis adjusting for age, gender, smoking, and total cholesterol, BMI was not associated with any study end point. In contrast, WHR (standardized adjusted odds ratios (OR) 2.01, 95% CI 1.02-3.93 for men and 2.63, 95% CI 1.38-5.00 for women), and WCf (OR ¼ 2.31, 95% CI 1.16-4.60 for men and 8.71, 95% CI 1.78-42.68 for women) proved independently predictive of vascular mortality. Additional adjustment for diabetes and hypertension did not substantially alter these results. Also, the predictive value of WHR and Wcf was retained after adjustment for drug treatment and the presence of significant coronary artery disease at baseline. Further, WHR and WCf were associated with total mortality, major coronary events, and cumulative vascular end points. CONCLUSION: Both total and central obesity are associated with insulin resistance and with an atherogenic lipoprotein profile. However, only central obesity is significantly and independently predictive of the 2-y vascular mortality in coronary patients.
Introduction
Despite enormous efforts of the medical community and of public health authorities in the fight against obesity, the prevalence of overweight and obesity has been increasing during the past 20 y. 1 Obesity is associated with a number of cardiovascular risk factors 2 and increases the incidence of cardiovascular disease. 3 In particular, central obesity is strongly correlated with an atherogenic lipid profile 4 and with insulin resistance. 5 Central obesity is a characteristic feature of the metabolic syndrome 6 and particularly increases the risk of atherosclerotic disease. 2 Although the associations of a high body mass index (BMI) and of measures of central obesity such as waist circumference (WCf) or waist-to-hip ratio (WHR) with the incidence of coronary artery disease (CAD) have been well established in population-based studies, the clinical importance of these risk factors for disease progression has not been thoroughly examined in patients already affected by CAD. Cardiovascular risk factors in high-risk patients, however, are of particular clinical interest. Therefore, we tested the hypothesis that anthropometric markers of total and central obesityFBMI, WHR, and WCfFin patients undergoing coronary angiography for the evaluation of CAD are risk factors for future vascular mortality.
Methods
Between September 1999 and October 2000 we enrolled 756 consecutive Caucasian patients, 513 men and 243 postmenopausal women, who were referred for coronary angiography for the evaluation of CAD. Information on conventional cardiovascular risk factors (history of smoking, hypertension, and established diabetes mellitus) was obtained by a standardized interview; and systolic/diastolic blood pressure was measured by the Riva-Rocci method under resting conditions in a sitting position at the day of hospital entry at least 5 h after hospitalization. Diabetes mellitus was diagnosed according to WHO criteria. 7 Height and weight as well as waist and hip circumferences were recorded according to the recommendations of the Airlie consensus conference; 8 BMI was calculated as body weight (kg)/height (m) 2 , and WHR as WCf/hip circumference. Coronary angiography was performed at baseline as described earlier. 9 Cine angiograms were reviewed by at least two experienced cardiologists without knowledge of the subjects' metabolic status. Stenoses were identified, and the percentage of lumen diameter stenosis was assessed by visual analysis. Significant coronary artery disease was defined as the presence of stenoses Z50%.
Venous fasting blood samples were collected on the morning of the day at which angiography was performed, as described earlier.
9,10 LDL cholesterol was measured directly (QuantolipLDL, Immuno, Austria). The serum levels of triglycerides, total cholesterol, and HDL cholesterol were determined by using enzymatic hydrolysis and precipitation techniques (Triglycerides GPO-PAP, CHOD/PAP, Roche, Switzerland and QuantolipHDL, Immuno, Austria) on a Hitachi-Analyzer 717 or 911. Glucose levels from venous fluoride plasma were measured enzymatically by the hexokinase method (Roche, Switzerland) on a Hitachi 717 or 911. Serum insulin was measured by an enzyme immunoassay on an AIA 1200 (Tosoh, Belgium). Insulin resistance was calculated using the homeostasis model for the assessment of insulin resistance (HOMA-IR).
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From March 2002 through January 2003, we invited the 756 patients recruited at baseline for a follow-up visit. Vascular mortality, including fatal myocardial infarction, sudden cardiac death, mortality from congestive heart failure due to CAD, and fatal ischemic stroke was recorded as the primary end point; secondary end points were: total mortality (mortality of any cause); major coronary events (sum of fatal and nonfatal myocardial infarction, sudden cardiac death, and mortality from congestive heart failure due to CAD); and cumulative vascular events (sum of vascular mortality, nonfatal myocardial infarction; nonfatal stroke; need for coronary artery bypass grafting, percutaneous coronary intervention or vascular surgery at the carotid or peripheral arteries). Causes of mortality were obtained from hospital records and from a national survey (Statistik Austria, Vienna, Austria). Nonfatal end points were queried in a standardized interview. Referring physicians were contacted for confirmation and for details on potential end points. All end points were independently reviewed by two of the authors (TM, PL), who were not involved in the data collection at baseline.
Myocardial infarction was diagnosed in the presence of two out of three criteria: (i) standard electrocardiographic criteria; (ii) ischemic cardiac pain; and (iii) creatinine kinase isoenzyme MB activity of at least twice the upper limit of normal. Cerebrovascular stroke was defined as a neurological deficit lasting Z48 h together with a computer tomography or magnetic resonance image consistent with ischemic stroke. Angioplasty and vascular surgery were considered end points unless they were planned as a consequence of baseline angiography. The Ethics Committee of the University of Innsbruck approved the present study, and all participants gave written informed consent. 
Statistical analysis

Results
Baseline characteristics
Baseline demographic characteristics of our patients (Table 1) were typical for a cohort undergoing coronary angiography, with a preponderance of male gender and a high prevalence of diabetes, hypertension, and smoking. 
Prospective analyses
The mean follow-up time was 2.2 (70.4) y for all patients, 2.3 (70.2) for those who survived to the follow-up visit, and 1.2 (70.9) for those who died during the follow-up period. Vascular death occurred in 3.8% of patients (n ¼ 29), and the overall incidence of vascular events was 12.8% (n ¼ 97). a Including fatal myocardial infarction, sudden cardiac death, mortality from congestive heart failure due to CAD and fatal ischemic stroke. b Including fatal and nonfatal myocardial infarction, sudden cardiac death, and mortality from heart failure due to CAD. c Grand total of vascular mortality, nonfatal myocardial infarction, nonfatal stroke, coronary artery bypass grafting, percutaneous coronary intervention, and vascular surgery at the carotid or peripheral arteries. CAD+ denotes patients with significant coronary artery stenoses Z50%. CADÀ denotes patients without significant coronary artery stenoses Z50%.
Obesity and vascular mortality in coronary patients G Hoefle et al were associated with total mortality, with major coronary events, and with cumulative vascular events (Table 4) . Additional adjustment for diabetes and hypertension did not substantially alter these results (Table 4) .
Analyses in the whole study group adjusting additionally for drug treatment revealed that the associations between WHR and WCf and vascular mortality were independent from drug treatment, with standardized adjusted OR of 1.90 (1.28-2.81); P ¼ 0.001 and 3.94 (1.93-8.02; Po0.001). Standardized adjusted OR were 1.55 (1.11-2.15; P ¼ 0.009) and 1.71 (1.02-2.84; P ¼ 0.040) for total mortality, 1.71 (1.17-2.50; P ¼ 0.006) and 2.21 (1.27-3.84; P ¼ 0.005) for major coronary events, and 1.43 (1.08-1.89; P ¼ 0.014) and 1.49 (1.01-2.19; P ¼ 0.044) for cumulative vascular events for WHR and WCf, respectively.
The incidence of vascular events was higher among patients with significant CAD at baseline than among patients who did not have significant CAD at baseline (Table 3) . Additional adjustment for the presence of significant coronary stenoses 50% at baseline showed that the associations of WHR and WCf with vascular mortality were independent from the coronary status at baseline, with standardized adjusted OR of 1.89 (1.27-2.81; P ¼ 0.002) and 4.24 (2.03-8.88; Po0.001). Standardized OR were 1.51 (1.10-2.08; P ¼ 0.011) and 1.90 (1.12-3.23; P ¼ 0.017) for total mortality, 1.64 (1.12-2.39; P ¼ 0.011) and 2.20 (1.26-3.85; P ¼ 0.005) for major coronary events, and 1.37 (1.04-1.81; P ¼ 0.026) and 1.47 (1.00-2.17; P ¼ 0.048) for cumulative vascular events for WHR and WCf, respectively, after additional adjustment for the presence of significant stenoses at baseline.
As can be seen in Figure 1 , both WHR and WCf were significantly predictive for vascular mortality among patients with significant CAD (OR ¼ 1.76 (1.15-2.68); P ¼ 0.009 and OR ¼ 3.91 (1.72-8.91); P ¼ 0.001, respectively) after multivariate adjustment including drug treatment. Also, these markers of central obesity were associated with total mortality, with major coronary events, and with cumulative vascular end points among patients with significant CAD at baseline. OR of patients without significant CAD were not Including fatal and nonfatal myocardial infarction, sudden cardiac death, and mortality from heart failure due to CAD.
d Grand total of vascular mortality, nonfatal myocardial infarction, nonfatal stroke, coronary artery bypass grafting, percutaneous coronary intervention, and vascular surgery at the carotid or peripheral arteries. Waist-to-hip ratio ¼ WHR; waist circumference ¼ WCf.
Obesity and vascular mortality in coronary patients G Hoefle et al significantly different from those with significant CAD (P for interaction WHR Â CAD ¼ 0.323 for vascular mortality, 0.511 for total mortality, 0.286 for major coronary events, and 0.773 for cumulative vascular events; P for interaction Wcf Â CAD ¼ 0.422 for vascular mortality, 0.478 for total mortality, 0.178 for major coronary events, and 0.429 for cumulative vascular events). However, because of the low absolute number of end points in patients without significant CAD, confidence intervals were wide.
Discussion
The data from our prospective study highlight a paramount role of central obesity as a cardiovascular risk factor in patients undergoing coronary angiography. We present the novel finding that in this high-risk population both WHR and WCf are significant predictors of vascular death both among men and women in as short a follow-up period as 2.2 y. In contrast, we did not find a significant association between total obesity as assessed by BMI and the short-term incidence of vascular death in either gender. Consistently, WHR and WCf but not BMI were associated with total mortality, with major coronary events, and with the overall incidence of vascular events. At baseline BMI as well as WHR and WCf correlated positively with triglycerides, with fasting insulin and with insulin resistance, and negatively with HDL cholesterol. Also, patients with diabetes mellitus and hypertension had a higher BMI, a higher WHR, and a higher WCf. Insulin resistance, 12 high triglycerides, 13 low HDL cholesterol, 14 diabetes mellitus, 15, 16 and hypertension 17 are associated with an increased cardiovascular risk. Consistent with their associations with these cardiovascular risk factors, WHR and WCf proved predictive of vascular mortality in our cohort. In contrast, we did not find a significant association of BMI with vascular mortality despite of its association with cardiovascular risk factors. This is in line with several crosssectional angiographic studies that failed to demonstrate an association between BMI and the prevalence of CAD in patients undergoing coronary angiography. [18] [19] [20] In agreement with our investigation, two recent prospective investigations on women undergoing coronary angiography failed to detect a significant association between BMI and adverse vascular events. 21, 22 Even an inverse association between BMI and cardiac mortality has been described in coronary patients after percutaneous coronary intervention. 23 Furthermore, in a population-based study, the association of BMI with the CAD incidence in older men was much weaker than in younger men, and WHR proved superior to BMI as a predictor of CAD in this age group. 24 Accordingly, the relatively high mean age of our patients (61 y for men and 66 y for women) could have contributed to the lack of an association between BMI and vascular mortality in our investigation. Although the role of a high Figure 1 Waist circumference and waist-to-hip ratio as predictors of study end points in all patients and with respect to CAD status.
Obesity and vascular mortality in coronary patients G Hoefle et al BMI as a cardiovascular risk factor in the general population is well known, 24-26 our data do not support a role for BMI to assess the prognosis of patients undergoing coronary angiography. Several cross-sectional angiographic studies have demonstrated an association between angiographic CAD and measures of central obesity. [18] [19] [20] In extension to these data we report that central obesity (in contrast to overall obesity) is an important predictor of vascular mortality both among men and women undergoing coronary angiography for the evaluation of CAD. It has been suggested that WCf is a better estimate of central obesity than WHR; 27 however, others find a comparable performance of the two parameters of central obesity. 28 Furthermore, WCf has been described to be more closely correlated with an atherogenic lipid profile than WHR. 29 Concordantly, in our study, WCf in both genders correlated slightly stronger with HOMA insulin resistance, with fasting plasma glucose, and with triglycerides than did WHR. However, in the prospective part of our study, both WHR and WCf proved significantly predictive of vascular mortality among both men and women. Diabetes and hypertension are considered intermediate steps in the causal path between obesity and coronary atherosclerosis. 30 Indeed, both BMI as a measure of total obesity and WHR as well as WCf as measures of central obesity were significantly higher in our patients with diabetes mellitus or hypertension. However, when weFlike the investigators of the Framingham Heart Study 26 Fadjusted for diabetes and hypertension in Cox regression models, the association between central obesity and vascular mortality in our investigation was not substantially weakened. This suggests that diabetes and hypertension, even though associated with central fat deposition, do not account for the full amount of cardiovascular risk inferred by central obesity.
In subgroup analyses with respect to the presence of significant CAD at baseline, both WCf and WHR proved significantly predictive of vascular mortality among patients with significant CAD. This indicates that central obesity further increases the high vascular risk of patients with angiographically proven significant CAD. The OR among the patients without significant CAD did not differ significantly from those among patients with significant CAD, but WHR and WCf were not significantly predictive for the low number of study end points in patients without significant CAD.
From our investigation in 756 patients over 2.2 y, we cannot exclude that with the greater statistical power of a larger study or a longer duration of follow-up, a significant association between BMI and vascular events could become demonstrable. However, we have found strong and significant associations between measures of central obesity and vascular mortality even during our limited duration of follow-up. This highlights the strong impact of central obesity on future vascular events among patients undergoing coronary angiography and thus stresses the clinical relevance of WHR and WCf.
Our study population is highly selected, and therefore our results should not be generalized to other populations. However, as the patients we have investigated are at a high risk of future cardiovascular events, prospective data on their cardiovascular risk factors are of major clinical interest.
In conclusion, our data highlight a major role of central obesity in predicting the short-term prognosis of patients undergoing coronary angiography for the evaluation of CAD. These very simply obtainable parameters of central fat distribution are paramount predictors of vascular mortality in patients requiring coronary angiography. Importantly, WHR and WCf are superior to BMI as risk indicators in coronary patients. Although it is premature to conclude at this stage that reducing weight would necessarily reduce risk among coronary patients, our results strongly support an enforced widespread use of WHR and WCf in the vascular risk assessment of patients undergoing coronary angiography. 
